Clinical Trial Update: Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism. [Phase 1]

View source ↗

Summary

Phase 1 pharmacodynamic and pharmacokinetic study of a slow-release aspirin formulation evaluating effects on platelet function; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Slow Release Aspirin (acetylsalicylic acid)

Snippet

Sponsor: Rottapharm Spain | Conditions: Cardiovascular Disease | Phase 1 | Status: COMPLETED